Light-dark patterns of soluble CD40 ligand: Clinical implications

American Heart Journal

Volumn 157, Issue 2, 2009, Pages

  Dominguez Rodríguez, Alberto ^a   Abreu Gonzalez, Pedro ^b  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND;

BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CONCENTRATION (PARAMETERS); GENETIC LINKAGE; HUMAN; LETTER; LIGAND BINDING; PRIORITY JOURNAL;

ANIMALS; CARDIOVASCULAR DISEASES; CD40 LIGAND; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 58649116461     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.11.005     Document Type: Letter

References (3)

1. Keaney Jr. J.F., Lipinska I., Larson M.G., et al. Clinical correlates, heritability, and genetic linkage of circulating CD40 ligand in the Framingham Offspring Study. Am Heart J 156 (2007) 1003-1009.e1
2. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M.J., et al. Diurnal variation of soluble CD40 ligand in patients with acute coronary syndrome. Soluble CD40 ligand and diurnal variation. Thromb Res (2008) (Electronic Publication 2008 June 23)
3. Rudnicka A.R., Rumley A., Lowe G.D., et al. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 115 (2007) 996-1003